528 related articles for article (PubMed ID: 11544330)
1. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
2. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
3. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
Yang W; Tabrizi M; Berrada K; Yi T
Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
[TBL] [Abstract][Full Text] [Related]
4. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
5. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.
Jiao H; Yang W; Berrada K; Tabrizi M; Shultz L; Yi T
Exp Hematol; 1997 Jul; 25(7):592-600. PubMed ID: 9216734
[TBL] [Abstract][Full Text] [Related]
6. Effects of sodium stibogluconate on differentiation and proliferation of human myeloid leukemia cell lines in vitro.
Pathak MK; Hu X; Yi T
Leukemia; 2002 Nov; 16(11):2285-91. PubMed ID: 12399974
[TBL] [Abstract][Full Text] [Related]
7. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
8. A negative role of SHP-2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival.
Chen J; Yu WM; Bunting KD; Qu CK
Oncogene; 2004 Apr; 23(20):3659-69. PubMed ID: 15116097
[TBL] [Abstract][Full Text] [Related]
9. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
Kim H; Hawley TS; Hawley RG; Baumann H
Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin induces tyrosine phosphorylation of a common beta subunit of GM-CSF receptor and its association with Stat5 in TF-1/TPO cells.
Ooi J; Tojo A; Asano S; Sato Y; Oka Y
Biochem Biophys Res Commun; 1998 May; 246(1):132-6. PubMed ID: 9600081
[TBL] [Abstract][Full Text] [Related]
12. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of sodium stibogluconate in synergy with IFNs.
Yi T; Pathak MK; Lindner DJ; Ketterer ME; Farver C; Borden EC
J Immunol; 2002 Nov; 169(10):5978-85. PubMed ID: 12421984
[TBL] [Abstract][Full Text] [Related]
14. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
15. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
16. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.
Minoo P; Zadeh MM; Rottapel R; Lebrun JJ; Ali S
Blood; 2004 Feb; 103(4):1398-407. PubMed ID: 14551136
[TBL] [Abstract][Full Text] [Related]
17. Involvement of protein phosphatase 2A in the interleukin-3-stimulated Jak2-Stat5 signaling pathway.
Yokoyama N; Reich NC; Miller WT
J Interferon Cytokine Res; 2001 Jun; 21(6):369-78. PubMed ID: 11440634
[TBL] [Abstract][Full Text] [Related]
18. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
You M; Yu DH; Feng GS
Mol Cell Biol; 1999 Mar; 19(3):2416-24. PubMed ID: 10022928
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation.
Matsuguchi T; Lilly MB; Kraft AS
J Biol Chem; 1998 Jul; 273(31):19411-8. PubMed ID: 9677359
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]